Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: January 2010
-
By Donald Zuhn –- On Friday, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its latest MoneyTree Report on venture funding. The study, conducted with PriceWaterhouseCoopers and Thomson Reuters, indicates that venture capitalists invested $5.0 billion in 794 deals in the fourth quarter…
-
January 25, 2010 – "Are Genes Patentable?" (Intellectual Property Litigation Committee, American Bar Association) – Atlanta & Seattle January 25-26, 2010 – European Pharmaceutical Regulatory Law Boot Camp (American Conference Institute) – New York, NY January 26-27, 2010 – Advanced In-House Counsel Forum on China IP Law (C5) – Shanghai, China January 27-30, 2010 –…
-
American Conference Institute (ACI) will be holding the spring session of its FDA Boot Camp conference on March 24-25, 2010 in New York, NY. ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices;• Comprehend the structure of the FDA and the roles of the…
-
C5 (UK) will be holding its 18th Forum on Biotech Patenting on March 17-18, 2010 in Munich, Germany. C5 faculty will provide information and insights into: • Strategies for adapting your patent practice to EPO rule changes;• The latest EPO requirements for the patentability of biotechnological inventions;• The practical impact of major EPO and national…
-
By James DeGiulio — With very little downside and huge upside, exclusivity is the driving force to the huge increase in first-to-file Paragraph IV filings. Adam Greene and D. Dewey Steadman, both at RBC Capital Markets Corp., conducted a recent study where they analyzed over 370 court rulings since the beginning of 2000 to…
-
By Donald Zuhn — The U.S. Patent and Trademark Office has announced that the Office and Department of Justice will not be seeking further review of the Federal Circuit's decision in Wyeth v. Kappos. In announcing this decision, the Office also stated that it is in the midst of "preparing guidance for expediting requests…
-
By Donald Zuhn — On Saturday, reports began to circulate regarding President Obama's recent interest in "renegotiating" the data exclusivity provisions of the health care bills that were passed in the House and Senate late last year (see "Snatching Defeat from the Jaws of Victory?"). In a discussion at the White House, the President…
-
By Kevin E. Noonan — Several weeks ago, U.S. District Court Judge Robert W. Sweet denied the U.S. Patent and Trademark Office's motion to dismiss the ACLU-sponsored lawsuit aiming for a human gene patenting ban (see "BRCA Patent Suit to Continue in Southern District of New York"). Just before Christmas, the Office filed another…
-
By Kevin E. Noonan — The efforts of the Obama Administration and Congressman Henry Waxman to reduce the term of the data exclusivity period contained in the House and Senate versions of the health care reform bill (12 years) has been noticed by others. The basic story is the same, but each new report…
-
Obama Administration Pushes for Lower Data Exclusivity Period By Kevin E. Noonan — The Obama administration is reported to be pushing for a lower data exclusivity period than the 12-year period contained in both the House and Senate versions of the health care reform bill. This latest twist was reported by Steve Usdin in…
Patent Docs 